Back

Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

31 August 2024 (13:00 - 13:40)
Organised by: Logo
Congress Presentation Part of: Heart failure: drug therapy and multidisciplinary care Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Shingo Matsumoto

Tokai University, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Systematic review and meta-analysis on the effects of physical activity-based interventions on frailty status and clinical outcomes in adults with long-term cardiac conditions.
Ms H. Waterhouse (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Assessing the practicality of a novel heart failure therapeutic score (QUAD Score) for drug optimisation in heart failure with a reduced ejection fraction
Doctor A. Ganapathy (Basildon, GB)
Abstract Slides Video
Presentation thumbnail
Short-term effects on sacubitril/valsartan therapy on right ventricle work and mechanics in patients with heart failure and reduced ejection fraction
Doctor J. Ottela (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Cardiovascular mortality with oral potassium-binders in patients with CKD and heart failure
Doctor H. Barzkar (Dallas, US)
Abstract Slides Video
Presentation thumbnail
The effects of angiotensin receptor-neprilysin inhibitors on clinical outcomes in heart failure with mildly reduced or preserved ejection fraction: real-world evidence from the CCA Database-HF Center
Doctor Z. Xie (Shanghai, CN) Professor J. Zhou (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: drug therapy and multidisciplinary care

The Event

Event poster

ESC Congress 2024

31 August 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Is beta- blocker therapy beneficial among patients with heart failure and reduced ejection fraction with concomitant atrial fibrillation rhythm?
thumbnail
Congress Presentation
Treating hypertensive patients with HFpEF: what is the role of beta-blockers?
thumbnail
Congress Presentation
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources